Fanconi anemia (FA) is a genome instability syndrome that is characterized by progressive bone marrow failure and a high risk of cancer. FA patients are particularly susceptible to leukemia as well as squamous cell carcinomas (SCCs) of the head and neck, anogenital region and skin. Thirteen complementation groups and the corresponding FA genes have been identified, and their protein products assemble into nuclear core complexes during DNA-damage responses. Much progress has been made in our understanding of post-translational FA protein modifications and physical interactions. By contrast, little is known about the control of protein availability at the level of transcription. We report here that multiple FA proteins were downregulated during the proliferative arrest of primary human keratinocytes and HeLa cells, and that the observed regulation was at a transcriptional level. Proliferative stimuli such as expression of HPV16 E7 as well as E2F1 overexpression in primary cells resulted in coordinate FA upregulation. To define the underlying mechanism, we examined the endogenous FANCD2 promoter, and detected regulated binding of members of the E2F/Rb family in chromatin immunoprecipitation assays. Finally, a 1 kb promoter fragment was sufficient to confer E2F/Rb regulation in reporter assays. Taken together, our data demonstrate FA gene co-regulation in synchrony with the cell cycle and suggest that deregulated expression of individual FA genes-in addition to FA gene mutation-may promote FA-related human cancer.
Introduction
Fanconi anemia (FA) is a genomic instability syndrome characterized by congenital defects, progressive aplastic anemia and cancer predisposition (Gurtan and D'Andrea, 2006; Patel and Joenje, 2007) . Disease incidence is rare, with 1 in 200 000 live births, and a heterozygote frequency of 1 in 250 (Joenje and Patel, 2001) . Diagnosis is often based on the constellation of birth defects, hematologic abnormalities and cellular hypersensitivity to DNA crosslinking agents such as diepoxybutane and mitomycin C. Results from the International FA Registry have revealed that FA patients are highly susceptible to hematologic as well as nonhematologic neoplasms (Alter, 2003; Kutler et al., 2003) . Of the nonhematologic tumors, squamous cell carcinomas (SCCs) of the head and neck (HN), anogenital region and skin are the most commonly diagnosed solid tumors. Few studies have so far addressed the role and regulation of FA pathways in human keratinocytes, the cell type of origin for SCCs.
Complementation of FA-specific defects has revealed 13 complementation groups, and the corresponding 13 FA genes have now been identified (Gurtan and D'Andrea, 2006; Meijer, 2007; Reid et al., 2007; Wang, 2007; Xia et al., 2007) . Hypothesized FA protein functions range from DNA repair, transcription and replication to oxidative stress responses (Bagby and Alter, 2006) . Even though the incidence of FA is extremely low, scientific interest in FA proteins continues to grow. This is due to the reported physical association of nuclear FA complexes with important known DNA repair proteins, such as BRCA1 and BRCA2, Rad51 and phosphorylated gH2AX, as well as multiple reports on the somatic inactivation of FA pathways in sporadic human cancers (Mathew, 2006) . As a consequence of DNA damage or during S phase, a nuclear core complex consisting of FA proteins A, B, C, E, F, G, L, M as well as FAAP24 and FAAP100 are assembled (Wang, 2007) . FA core complex formation leads to the monoubiquitination and relocalization of FANCD2 and FANCI to nuclear foci containing homologous recombination (HR)-associated proteins, such as BRCA1, BRCA2 (FANCD1) and Rad51 (Kennedy and D'Andrea, 2005) and subsequent DNA repair.
On the basis of the multitude of FA proteins and associated partners and thus relative system complexity, it is reasonable to speculate that the activity of individual FA family members must be highly coordinated. Previous reports on such coordination include the interdependence of FA core compex stability and nuclear import (Garcia-Higuera et al., 2001; Pace et al., 2002; Leveille et al., 2006) . We describe here an additional level of coordination at the level of transcription. The arrest of cellular proliferation in primary human keratinocytes and HeLa cervical cancer cells resulted in reduced levels of multiple FA proteins in a manner that correlated with mRNA expression. Studies of FANCD2 regulation in primary cells revealed enhanced expression following HPV16 E7-or E2F-stimulated proliferation, and reduced expression following expression of a constitutively active Rb molecule. Using chromatin immunoprecipitations (ChIPs), we demonstrate direct interactions between Rb/E2F complexes and endogenous FANCD2 promoter proximal sequences. Finally, a 1 kb FANCD2 promoter fragment was sufficient for recapitulating E2F/Rb regulation in reporter assays, thus supporting control of FA protein availability through transcriptional regulation. Together with the finding that FANCD2 knockdown in primary human keratinocytes was incompatible with cell growth, we postulate that co-induction of FA gene expression as a response to proliferative stimuli is a barrier to human carcinogenesis, and that deregulated FA gene transcription may promote human cancer.
Results
Repression of FA protein expression occurs during proliferative arrest of primary human keratinocytes Epithelial malignancies must by definition overcome the permanent cell-cycle arrest that is associated with cellular differentiation and senescence. To investigate FA protein availability and regulation in primary human foreskin keratinocytes (HFKs), we first utilized an established in vitro differentiation model whereby 1 mM calcium is added to the medium (Dotto, 1999) . In vitro differentiation is shown visually in Figure 1a , and was accompanied by the induction of involucrin expression (data not shown). Protein extracts were harvested on various days and subjected to immunoblot analyses. In line with a correlation between differentiation and FA gene repression, FANCC, FANCD2 and FANCG were repressed following the induction of cellular differentiation in these experiments.
We next asked whether FA protein repression similarly accompanies replicative senescence in primary HFKs. Cells from four different donors were carried until they were completely growth arrested at senescence. Protein extracts were harvested from proliferating versus senescent HFKs, and subjected to western blot analyses for the detection of FA protein expression (Figure 1b) . A representative SA-bGal stain is shown for cells from one donor, proliferating at passage 5 versus completely growth arrested at passage 13. As expected, expression of cyclin A protein levels was reduced in the senescent compared to the proliferating cell samples. Levels of FANCC, FANCD2 and also FANCJ protein were dramatically reduced at senescence for each donor cell population. Interestingly, in proliferating cells from one donor (lane 3), FANCD2 and FANCJ, but not FANCC protein levels are lower compared to the other donors. We cannot rule out decreased protein stability in this particular experiment. However, if lower transcriptional rates are responsible for the low levels of FANCD2 and J protein, natural variations in the expression of individual FA mRNAs may exist in the general population and perhaps even be risk factors for SCC development. FANCJ protein levels were not assessed in Figure 1a and FANCG levels were not assessed in Figure 1b . However, their respective repression would be expected in each case. Taken together, these data suggested reduced expression of multiple FA proteins during the proliferative arrest of primary keratinocytes. To determine the biological importance of FA gene repression in primary keratinocytes, we targeted FANCD2 expression specifically using two different lentiviral knockdown vectors as described in 'Materials and methods' (Figure 1c ). Primary cells were infected, selected in puromycin and equal cell numbers were subsequently plated. Immunoblot analysis on day 7 post-infection revealed strong FANCD2 repression by each targeting vector compared to control-infected cells. Interestingly, cell counts from the same day revealed a reduction in the number of viable cells with FANCD2sh4 compared to control-infected cells. Morphological examination and cell staining with methylene blue revealed an even more dramatic cell growth suppression phenotype on day 17 post-infection. We conclude that FANCD2 function is critical for the growth and survival of primary human cells.
Coordinate FA protein regulation correlates with mRNA expression HPV-positive HeLa cell growth depends critically upon expression of the two viral E6/E7 HPV oncogenes. E6/E7 transcription from integrated HPV18 genomes can be specifically downregulated via the introduction of E2, a viral gene that is usually disrupted in cervical cancer. Consequences of E2 expression and reactivation of cellular E6/E7 targets have been characterized extensively, and include cell-cycle arrest and subsequent senescence induction Wells et al., 2000) . We previously described the transcriptome signature of senescing HPV18-positive HeLa cervical cancer cells using Affymetrix microarrays and a temperature-sensitive E2 protein (Wells et al., 2003) . Interestingly, although several FA genes including FANCD2 and FANCJ were not present on the microarray, the data indicated repression of members of the FA gene family including FANCA and FANCG, as well as the FA-associated BRCA1 and Rad51 genes. The fully annotated dataset is available at http://genet.cchmc.org.
To determine whether co-regulation of FA protein expression may occur at the level of mRNA expression, HeLa cells were treated as previously described for the microarray experiments: Adenoviral delivery of a temperature-sensitive BPV1 E2ts protein was followed by temperature shift to the permissive temperature and thus synchronized senescence induction at 32 1C in the HeLa cell population (Wells et al., 2003) . Empty adenovirus (Ad)-infected control cells were treated in an identical fashion, and control infections at the restrictive temperature of 39.5 1C were included. Five components of the FA pathway, FANCA, C, G, D2 and D1/BRCA2 were repressed at the level of mRNA during HeLa cell senescence, as was the FA core complex-associated BRCA1 gene (Figure 2a ). In the case of FANCD2, the observed repression manifested as a trend rather than with statistical significance. HeLa cells were infected with either empty adenovirus (Ad) or Ad expressing a temperature-sensitive E2 protein (AdE2ts) as described in Wells et al. (2003) . Total RNA was harvested on day 3 and mRNA was converted to cDNA, followed by real-time PCR using primers specific for the indicated genes. Black bars represent the senescent cell samples. Each treatment was displayed as fold change relative to the control values (Ad32). Statistical significance for three independent experiments conducted at the permissive (32 1C) and restrictive (39.5 1C) temperature is indicated by asterisks (*) (*Po0.05, **Po0.01). The cyclin/cdk inhibitor p21 CIP was included as a positive control (Wells et al., 2000) . (b) Western blot analysis and senescence staining. HeLa cells were transduced with either empty pBABE, E2-TR or E2-TA expressing retroviruses, and selected in puromycin containing media. Protein lysates from day 5 were subjected to western blot analysis for the detection of cyclin A, FANCD2, FANCC, FANCG and actin. Morphological hallmarks of senescence and SA-bGal positivity in response to E2-TA, but not E2-TR are depicted on the right. (c) For FANCA and FANCG mRNA detection after chemically induced cell-cycle arrest, mimosine was added to the media at a final concentration of 0.4 mM for 24 h. This treatment resulted in an increase in the G 0 /G 1 HeLa cell population from 44 to 64% of the total cell population as determined by flow cytometric cell-cycle analysis (data not shown). Cont, solvent treated cells; Mim, mimosine-treated cells. (d) The human TSUPr-1 bladder cancer cell line was infected with either empty or p16INK4a-expressing Ad as described in 'Materials and methods' for the chromatin immunoprecipiations in Figure 4 . Cells were harvested after 48 h and FANCA and FANCG mRNA levels were quantitated by real-time PCR as in (c). Figure 1 Fanconi anemia (FA) protein levels are reduced during differentiation-and senescence-associated keratinocyte growth arrest states. (a). Differentiation: proliferating primary keratinocyte cultures were either left undifferentiated (À) or were differentiated ( þ ) via the addition of 1 mM calcium and 10% serum to the medium. The typical differentiation-associated appearance of the cultures is shown (right panel) in comparison to proliferating cells (left panel). Protein lysates were harvested on days 1-4 post-differentiation as indicated, and subjected to western blot analysis for the detection of FANCD2, FANCC, FANCG and actin. Normalization of each band to its respective actin control resulted in the following values for days 1 through 4, expressed as percent protein expression in differentiated compared to undifferentiated cells: FANCD2: 32, 45, 45, 36%. FANCC: 23, 29, 5, 37%. FANCG: 34, 17, 16, 10%. (b) Replicative senescence: protein lysates from early and late passage human foreskin keratinocytes cultured from four different donors (lanes 1 and 5, 2 and 6, 3 and 7, 4 and 8) were harvested, and western blot analyses were performed for cyclin A, FANCD2, FANCJ, FANCC and actin. SA-b-gal staining is depicted for donor 1 to verify the senescent cell phenotype. The percentages of SA-bGal-positive cells in proliferating versus senescent cells were 5 versus 84% for donor 1, 11 versus 93% for donor 2, 4 versus 86% for donor 3 versus 0 and 75% for donor 4. (c) Primary keratinocytes were infected with either lentiviral nontargeting control vector or with two different FANCD2 shRNA expression vectors, and selected in 1 mg/ml puromycin for 4 days. Equal cell numbers were plated and protein extracts were prepared on day 7 post-infection for FANCD2 detection by immunoblot analysis. Cell counts taken after trypsinization reflect the phenotypic cell growth suppression upon FANCD2 depletion (top panel) at this early time point. Control versus FANCD2sh4 infected cells were split equally and stained with methylene blue on day 17 post-infection. A representative field reveals cell morphology at this late time point in the middle panel, an image of the stained plate is shown on the bottom. NT: nontargeting control vector, D2sh3 and D2sh4: FANCD2 targeting vectors.
To confirm the observed FA gene regulation at the level of protein expression and using the wild-type E2-TA protein, we detected FANCC, G and D2 levels by immunoblot analyses. An N-terminally truncated, senescence incompetent E2-TR variant was utilized as a negative control for these experiments (Wells et al., 2000) . Retroviral pBABE E2-TA expression resulted in decreased HeLa cell proliferation (data not shown) and repression of the proliferative marker cyclin A, development of the typical morphological senescence features and positive staining for SAb-Gal over time as expected (Figure 2b ). Senescence was not detected following infection with pBABE E2-TR (Figure 2b ) or empty vector (data not shown). In agreement with a correlation between mRNA and protein expression, protein levels of FANCC, G and D2 were substantially reduced in response to E2-TA expression. Similar to the observed FA repression during differentiation and senescence, G 1 cell-cycle arrest of HeLa cells using mimosine or of TSUPr-1 cells using p16Ink4a overexpression resulted in reduced FANCA and FANCG mRNA levels ( Figures 2C AND D) . Taken together, our data suggest that the observed FA regulation was a consequence of senescence-associated cell-cycle arrest and not dependent upon senescence per se (data not shown).
FANCD2 expression is regulated by the E2F/Rb pathway
We next determined whether the HPV oncogenes as a proliferation stimulus could upregulate FA protein levels in primary cells. We focused on FANCD2 as an indicator of core complex assembly in these experiments. Normal spontaneously immortalized keratinocytes (NIKs) were utilized, either in the absence (lane 1) or in the presence (lane 2) of HPV (Figure 3a) . Reduced p53 levels in the NIK/HPV16 cells reflect the presence of HPV16 E6 and consequent p53 instability. FANCD2 levels were elevated in the presence of HPV16. HPV genomic DNA is known to immortalize primary HFKs, and expression of the viral E6/E7 oncogenes is sufficient for this process. We introduced HPV16 and 18 into HFKs using an established transfection and selection method (Fehrmann and Laimins, 2005) . The presence of either HPV 16 or 18 upregulated FANCD2 levels substantially (Figure 3b , compare lanes 1, 3 and 5). DNA damage induction by hydroxyurea (HU) treatment resulted in a detectable shift from the nonubiquitinated, short form of FANCD2 (FANCD2-S) to the slower migrating, monoubiquitinated form (FANCD2-L) (Figure 3b ). Greater levels of both nonand monoubiquitinated FANCD2-L protein were observed following DNA damage (compare lanes 2, 4 and 6), indicating that increased FA expression-at least in principle-translates into enhanced FA response pathways under conditions of DNA damage. These data are in agreement with a recent report from the Duensing Laboratory, where both soluble and chromatin-associated FANCD2 and FANCD1/BRCA2 protein levels were elevated by E7 (Spardy et al., 2007) . FANCD2 activation is often quantitated in the literature by the ratio of the FANCD2-L relative to the FANCD2-S band. Since both monoubiquitinated as well as nonubiquitinated FANCD2 increased with upregulated expression, we suggest that differences in total INK4a -mediated FANCD2 repression is shown on the left. (c) Reporter assays. TSUPr-1 cells were co-transfected with FANCD2 reporter containing the 1 kb promoter fragment indicated in (a), and either empty plasmid or p16INK4a expression vector. Luciferase activity was measured after 2 days. HeLa cells were transfected with 2 mg of FANCD2 reporter or empty pGL2B reporter as a control. The cells were superinfected on the next day with empty Ad or AdE2F1 expressing adenovirus, cell lysates were harvested and luciferase assays were performed after 3 days.
Transcriptional regulation of FA genes EE Hoskins et al FANCD2 protein levels might need to be incorporated in such quantitative assessments.
We next verified that E7 was indeed responsible for the observed FANCD2 upregulation. Primary human HFKs were transduced with either empty LXSN retroviral vector, HPV16 E6-, E7-or E6/E7-expressing vector as previously described (Wise-Draper et al., 2005) , and relative FANCD2 protein levels were detected (Figure 3c ). The data confirmed E7 as a positive regulator of FANCD2 expression (compare lanes 3 and 4 with lanes 1 and 2). The apparent slight decrease in FANCD2 levels in E6 transduced cells (lane 2) was not consistently observed, either in our study or in the study by Spardy et al. (2007) . Given that E2F transcription factor activity is stimulated by E7 and that E2F transcriptional activity is important for cellcycle progression, we next asked whether FA gene expression is under the control of Rb/E2F pathways in the absence of HPV (Figure 3d ). HFKs were infected with either empty Ad as a control or with Ads expressing E2F1, E2F2 or a constitutively active Rb allele PSM-Rb.7LP . Upregulated FA protein expression occurred in response to E2F1 or E2F2, as well as downregulated FA expression in response to active Rb.
FANCD2 regulation involves E2F/Rb binding to promoter sequences
Of several FA genes with conserved consensus E2F-binding motifs close to the transcriptional start site (data not shown), we chose the FANCD2 promoter for further examination by ChIP and reporter analyses (Figure 4a) . To activate the endogenous Rb pathway, adenoviral transduction of TSUPr-1 cells with p16INK4a was utilized (Gunawardena et al., 2004) . Western blot analysis confirmed substantial downregulation of FANCD2 by p16
INK4a at the level of protein expression (Figure 4b) , and the co-repression of FANCA and G at the level of mRNA was verified in this cell system (Figure 2d ). Within the E2F family, activating E2F1-3 are distinguished from repressive E2F 4-5 proteins. Promoter repression by members of the retinoblastoma protein family involves direct binding to E2Fs, the recruitment of histone deacetylases and promoter hypoacetylation (Cobrinik, 2005) . ChIP analyses of FANCD2 promoter proximal sequences were performed for the detection of acetylated histone H4, the repressive E2F4 family member and the p107/p130 retinoblastoma family members. The antibody to Dbf-4 was utilized as a negative control, since the replication factor Dbf-4 was not expected to occupy these promoters. Decreased acetylation and a switch to promoter occupancy by the p130/E2F4 transcriptional repression complex upon p16INK4a overexpression correlated with decreased expression levels of FANCD2 in these experiments (Figure 4b) . In parallel, a 1 kb FANCD2 promoter fragment (Figure 4a ) was cloned into the pGL2 luciferase plasmid and tested in reporter assays (Figure 4c ). Co-transfection of TSUPr-1 cells with the pGL2B-FANCD2 reporter and a pCMV-neo-based p16INK4a expression vector resulted in dramatic FANCD2 promoter repression (left panel). Conversely, the adenoviral overexpression of E2F1 or E2F2 in HeLa cells (overexpression data not shown) resulted in FANCD2 promoter activation (right panel), suggesting that the respective sequences were sufficient for promoter responsiveness to E2F/Rb. Taken together, our data indicate transcriptional FA gene repression during various forms of cellular growth arrest, and activation in response to proliferative stimuli, and support direct E2F/Rb promoter interactions as the underlying molecular mechanism.
Discussion
Intact FA functions are clearly important for the maintenance of a hematopoietic compartment and for cancer prevention. However, precise molecular roles of FA proteins, presumed to mediate protection from DNA and oxidative damage (Pagano and Youssoufian, 2003; Kennedy and D'Andrea, 2005) , have remained relatively elusive. In response to DNA damage or during S phase, a cooperative network of FA protein interactions results in the assembly of a multiprotein nuclear core complex followed by the monoubiquitination and translocation of FANCD2 and FANCI to chromatinassociated nuclear foci. Focal co-localization with HRassociated Rad51 as well as the BRCA1, BRCA2/ FANCD1 and BACH1/BRIP1/FANCJ breast cancer susceptibility gene products is observed, and FA pathways presumably coordinate DNA replication with HR and translesion synthesis (Niedzwiedz et al., 2004) . The loss of such functions is in agreement with the observed chromosomal instability and high cancer incidence in FA patients (Mathew, 2006) . In agreement with a requirement for intact FA functions in primary human keratinocytes, lentiviral knockdown of FANCD2 was sufficient for causing a dramatic cellular growth suppression phenotype, perhaps as a result of extensive DNA damage (Figure 1c) . As two different FANCD2sh expression vectors yielded similar results in comparison with nontargeting control vector, we do not believe that the observed phenotype represents a nonspecific interferon response to the RNAi vectors (Bridge et al., 2003) . Additionally, treatment of primary keratinocytes with interferon-b for 6 days has been shown to affect cellular growth only modestly (Chang et al., 2002) , suggesting that such an interferon response could not by itself account for the dramatic cellular growth suppression. Our data may suggest that the rare incidence of FA in humans reflects the lack of compatibility of human embryonic development, at least in the epithelial lineage, with FA loss.
Given the ordered involvement of a large number of FA proteins and their regulated assembly during S phase (Taniguchi et al., 2002) , it is not surprising that protein availability is controlled at the level of transcription and in synchrony with the cell cycle as our data would suggest. Cross talk between E2F and the FA pathway was recently postulated based on in-silico analyses, and the overexpression of E2F1 in normal fibroblasts indeed resulted in elevated levels of FANCC mRNA (Tategu et al., 2007) . Interestingly, while FANCA, C and J mRNA expression were reported upregulated in E2F1 overexpressing HeLa cells using reporter assays in this study, no such upregulation was observed for other members of the family including FANCD2. It remains to be seen whether these differences are due to different reporter constructs utilized, the level of E2F overexpression or the timing at which the assays were performed. FA suppression was detected in response to the expression of constitutively active Rb, endogenous activation of Rb family members by p16 INK4a and two natural forms of proliferative cell-cycle arrest, senescence and differentiation, both of which involve Rb hypophosphorylation and activation (Kobayashi et al., 1994; Kiyono et al., 1997) . Rb-mediated FANCD2 repression correlated with decreased histone H4 acetylation of the endogenous promoter, and a switch to promoter occupancy by the E2F4 and p130, the most prominent Rb family member in arrested cells (Classon and Dyson, 2001) . By contrast, cellular proliferation stimuli such as E7 or E2F1/2 resulted in upregulated FA mRNA and protein expression. E2F-controlled FA gene regulation implies that FA mRNA levels and thus protein availability should be highest in S phase when the threat of DNA damage is particularly acute. Indeed, upregulated levels of FANCC, FANCG and FANCD2-S were observed in HPV-positive as well as E2F overexpressing cells (Figure 3) . We do not believe that FA transcriptional regulation by E7 is separate from E2F-both upregulate FA gene expression. However, the E6/E7 oncoproteins are additionally known to induce DNA damage through Rb/E2F-independent mechanisms (Duensing and Munger, 2004) . This is perhaps best reflected in Figure 3b , where the presence of HPV16 and HPV18 correlates with increased levels of both monoubiquitinated and nonubiquitinated FANCD2 levels in nondamaged cells (lanes 3 and 5), with further elevation of ubiquitinated FANCD2 upon HU treatment (lanes 4 and 6). The absence of ubiquitinated FANCD2 in the presence of HPV in Figure 3a is unclear, but may be due to lower E6/E7 expression levels in this experiment. Our findings are in agreement with recent data from the Duensing Laboratory, where the E7 oncoprotein was shown to upregulate both the levels and activation of FANCD2 (Spardy et al., 2007) . This same report suggested that HPV-induced genome instability cooperates with the loss of FA function to exacerbate DNA damage, thus generating a cellular environment that selects heavily for clonal transformation. Taken together, increased availability of FA components in S phase would ensure that DNA replication, associated damage and resulting mutations will be met with appropriate levels of DNA repair. Under conditions of inappropriate proliferation, FA transcriptional induction may contribute an important cellular defense to prevent deleterious mutations and ultimately neoplastic transformation.
FA pathway activity has been associated with resistance to chemotherapeutic approaches such as DNA crosslinkers in pancreatic cancer and multiple myeloma (Chen et al., 2005; van der Heijden et al., 2005) , as well as DNA alkylating agents in glioma . It is tempting to speculate that under certain circumstances, E2F activity might aid in the development of drug resistance through stimulating FA pathway activity and DNA repair. Interestingly, gene expression signatures of platinum-resistant advanced stage ovarian cancers revealed activation of E2F3 pathways, and the targeting of E2F pathways with roscovitine could be exploited for improved response to chemotherapy in vitro (Dressman et al., 2007) . Additionally, high levels of activating relative to repressing E2Fs have recently been shown to be clinical predictors of poor response to chemotherapy in ovarian cancer patients (Reimer et al., 2007) . Future analyses of the relative contribution of FA upregulation to E2F-dependent chemotherapy resistance in cancer patients will be important for an assessment of possible treatment implications.
Although the full complement of E2F-regulated FA family members and associated genes has not yet been defined, the observed co-regulation of FANCA, C, G, D2, J and D1/BRCAII BRCAI may indicate that at least a subset of FA complex proteins is transcriptionally limiting. Definition of the relevant subset is ongoing, but at least one additional FA gene, FANCB, was noted by the DiMaio Laboratory as repressed in response to E2-mediated E7 repression in HeLa cells (Johung et al., 2007; supplementary data) . Published reports on the E2F-dependent repression of Rad51 and BRCA1, specifically during hypoxia, (Oberley et al., 2003; Bindra and Glazer, 2006; Bindra et al., 2007) , together with the repression of these two molecules in our microarray experiments (data not shown) and in Figure 2a , respectively, may imply coordination with a wider network of DNA repair pathways. With regard to human cancers exhibiting high E2F activity and rapid cell proliferation, the deregulation of individual, but not necessarily multiple, components of the system may be responsible for insufficient DNA repair, high mutational frequencies and carcinogenesis. Transcriptional BRCA1 repression in the absence of genetic mutations has been reported for sporadic tumors and has been linked to poor prognosis in patients with breast cancer (Thompson et al., 1995; Russell et al., 2000) . Repression of FA gene transcription by an unknown mechanism was also reported for sporadic HN cancers (Wreesmann et al., 2007) as well as ovarian cancers (Pejovic et al., 2006) . Finally, disruption of transcriptional co-regulation may also occur through epigenetic mechanisms, as has been shown with the hypermethylation of FANCF and at a lower frequency for BRCA1 and BRCA2 in cervical, lung and oral as well as ovarian cancers (Dhillon et al., 2004; Marsit et al., 2004; Narayan et al., 2004) . A recent publication from the D'Andrea Laboratory has reported hyperdependence of FA-deficient cells on alternative DNA repair pathways for survival, and has offered specific directions as to the targeting of such pathways (Kennedy et al., 2007) . Identification of the full complement of E2F-regulated, FA-associated genes and continuous monitoring of their expression in cancer patients may become one diagnostic tool to define early time points at which such treatments might be clinically indicated.
Materials and methods

Cell culture
Caski, HeLa and C33A cell lines were maintained as described (Wise-Draper et al., 2005) . Primary HFKs were maintained in Epilife Medium supplemented with HKGS (Cascade Biologics, Portland, OR, USA). The cells were split 1:4 when they reached 80% confluence and senesced between 8 and 13 passages depending upon the donor. HPV-positive and -negative NIKs were gifts from Paul Lambert, University of Wisconsin-Madison, and were carried as previously described (Nakahara et al., 2005) . Irradiated J2-3T3 cells were used as feeder cells.
HPV genome transfections HPV16 and HPV18 genomic DNA was excised from PML2D-HPV16 and pBR322-HPV18 (a gift from the Howley Laboratory) using BamHI and EcoR1, respectively, recircularized and transfected into HFKs as previously described (Fehrmann and Laimins, 2005) .
Viral constructs
The retroviral pBABE-based E2-TR, and E2-TA vectors were generated using the BPV1 E2-TR and E2-TA open reading frames cloned into the pGEM-T Easy vector (Promega, Madison, WI, USA), sequenced, excised using BamHI and XhoI, and cloned into BamHI and SalI cut pBABE vector. LXSN, 16E6, 16E7, 16E6/E7 retroviral vectors as well as AdGFP, AdE2-TR, AdE2-TA and AdE2ts adenoviral vectors were previously described (Wise-Draper et al., 2005) . The AdE2F1, E2F2 and PSM-RB.7LP adenoviral vectors were previously described , and were used for HFK infections at 150 plaque-forming units per cell. Nontargeting and FAND2-specific shRNA-expressing lentiviral vectors were obtained through the Sigma MISSION shRNA program (Sigma-Aldrich, St Louis, MO, USA). Relevant product numbers were SHC 002V for the nontargeting control vector (NT), TRCN0000082840 for the FANCD2sh3 and TRCN0000082841 for FANCD2sh4 targeting vector. Western blot analysis For the Laemmli extraction method, cells were lysed using Laemmli buffer (100 mM Tris-HCl, pH ¼ 6.8, 15% glycerol, 4% SDS and bromophenol blue), boiled for 10 min and centrifuged (Laemmli, 1970) . Western blot analysis using RIPA or Laemmli extracts was performed as previously described (Wise-Draper et al., 2005) . Antibodies used were: cyclin A (H-432, Santa Cruz Biotechnology, CA, USA), p53 (Ab-6 OP43L EMD Biosciences, San Diego, CA), FANCC (H541-558) and FANCG (H604-622) (generous gifts from the Fanconi Anemia Research Fund through the Oregon Health and Science University), FANCD2 and FANCJ (Novus Biologicals, Littleton, CO, USA) and actin (a generous gift from the Lessard Laboratory).
SA-b-Gal staining
Staining for perinuclear senescence-associated b-galactosidase activity was performed as previously described (Dimri et al., 1995) .
Chromatin immunoprecipitations
Primers for the ChIP experiments were 5 0 -CTTCTCT CTGACGTCGCCTCT and 5 0 -GACTACGACCATTGCTC CACTTAC. The human TSUPr-1 bladder cancer cell line was infected with either green fluorescent protein or p16INK4a-expressing Ad as previously described (Angus et al., 2002) , and ChIP analysis was performed according to (Siddiqui et al., 2003) . The following antibodies were utilized: p107 (SC-318), p130 (SC-317), E2F4 (SC-1082), Dbf4 (SC-11354), all from Santa Cruz Biotechnology. The acetylated histone H4 antibody (06-866) was from Upstate Biotechnology, Lake Placid, NY, USA).
Luciferase reporter assays
Primers for isolation of a 1000 bp promoter fragment for reporter assays were 5 0 -CACCCTAGGAAGGGAAATGATA and 5 0 -CTACGACCATTGCTCCACTTAC. The amplicon was subcloned into the firefly luciferase expression vector pGL2-Basic (Promega), and sequenced. HeLa cells were transfected with the FANCD2 reporter or control vector, superinfected with AdE2F1 and harvested on day 3 postinfection. The cells were counted, and equal cell numbers were utilized for luciferase assays as previously described (Wells et al., 2003) . For reporter assays in TSUPr-1 cells, these were co-transfected with FANCD2 reporter and either p16ink4a expression or control vector. The cells were harvested for luciferase assays at 48 h post-transfection.
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